Archive - March 2019
Daiichi Sankyo starts mirogabalin trial in spinal injury pain
UK business: Brexit deadlock causing “frustration and anger”
NICE recommends MSD’s diabetes drug Steglatro
New pharma Azadyne raises £1.5m for autoimmune disease treatment
NHS aims for one link worker per primary care network from July
AZ’ Imfinzi to be funded for NHS use via CDF
Number of prescription rises but cost falls again
SpaceX CEO Elon Musk Envisions ‘Self-Sustaining’ Mars City In Next 30 Years